ADC Therapeutics (ADC Therapeutics) Price-to-Operating-Cash-Flow : (As of Apr. 28, 2024)

View and export this data going back to 2020. Start your Free Trial

What is ADC Therapeutics Price-to-Operating-Cash-Flow?

As of today (2024-04-28), ADC Therapeutics's share price is $4.34. ADC Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.45. Hence, ADC Therapeutics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for ADC Therapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:

ADCT's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.65
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

ADC Therapeutics's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $-0.40. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.45.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 17.40% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 5.10% per year.

During the past 8 years, ADC Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 17.40% per year. The lowest was -26.60% per year. And the median was -6.35% per year.

ADC Therapeutics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for ADC Therapeutics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ADC Therapeutics Price-to-Operating-Cash-Flow Chart

ADC Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

ADC Therapeutics Quarterly Data
	Dec18	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of ADC Therapeutics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, ADC Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ADC Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ADC Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where ADC Therapeutics's Price-to-Operating-Cash-Flow falls into.

ADC Therapeutics Price-to-Operating-Cash-Flow Calculation

ADC Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	4.34	/	-1.451
	=

ADC Therapeutics's Share Price of today is $4.34.
ADC Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.45.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

ADC Therapeutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of ADC Therapeutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

ADC Therapeutics (ADC Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ADC Therapeutics SA (NYSE:ADCT) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

Route de la Corniche 3B, Biopole, Epalinges, CHE, 1066

Website

https://www.adctherapeutics.com

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.